Interventional Cardiology

Women had similar three-year outcomes with FFR-guided PCI and CABG, whereas men had better outcomes with CABG in FAME 3.

ACURATE neo2 TAVI shows strong 30-day outcomes in severe bicuspid aortic stenosis, with high device success and safety.

Coronary events post-TAVR are uncommon but serious. Patients undergoing PCI have better outcomes, especially with balloon-expandable valves.

The Myval THV series is non-inferior to SAPIEN and Evolut THV series at 30 days, offering a promising TAVI alternative.

Polymer-free stents match biodegradable-polymer stents in PCI outcomes but pose a higher early thrombosis risk, requiring careful clinical consideration.

Photon-counting CT outperforms conventional imaging for coronary artery disease, reducing invasive procedures and improving accuracy.

New imaging data show TriClip reduces tricuspid regurgitation and reverses cardiac remodeling, sustaining benefits for one year.

Innovative wearable ACG technology shows promise as a non-invasive diagnostic tool for SLT after TAVR.